Dashboard
Financial statements
MTD

Company financials

Mettler Toledo

Health Care Life Sciences Tools & Services Columbus, Ohio Last filing Feb 6, 2026 · FY2025
Revenue FY2025
$4.0B
3y CAGR +0.9% P22
Net income FY2025
$869.2M
Net margin +21.6% P82
Total assets FY2025
$3.7B
ROA +23.4% P98
Operating cash flow FY2025
$955.8M
FCF margin +21.1% P76
18 yrs · FY2008–FY2025 9 filed · 0 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 10 years
Total assets $3.7B
Total liabilities $3.7B
Shareholders equity $-23.6M
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents 1.7% 1.5% 1.8% 2.4% 2.7% 3.1% 6.9% 6.1% 5.5% 6.3%
Accounts Receivable 19.3% 17.7% 17.5% 18.1% 17.4% 19.2% 18.8% 18.2% 19.4% 18.1%
Inventory 9.6% 8.8% 10.2% 11.3% 11.1% 9.6% 9.1% 9.2% 9.4% 8.9%
Prepaid Expenses 3.2% 2.7% 2.9% 3.3% 2.9% 2.3% 2.0% 2.2% 2.7% 2.4%
Other Current Assets 11.0% 8.1% 8.8% 8.8% 7.1% 5.5% 5.0% 2.3% 2.5% 1.2%
Total Current Assets 33.8% 30.8% 32.5% 35.1% 34.1% 34.3% 36.9% 35.6% 36.9% 35.8%
Property,Plant and Equipment 21.0% 19.9% 21.2% 19.9% 21.5% 25.9% 24.9% 24.4% 24.5% 22.5%
Goodwill 18.4% 17.3% 17.7% 16.8% 17.4% 17.8% 17.8% 18.2% 19.8% 19.0%
Intangible Assets 6.9% 6.6% 7.5% 7.8% 8.3% 6.4% 6.9% 7.4% 8.3% 6.7%
Deferred Tax Assets 1.0% 0.9% 0.8% 0.7% 1.1% 1.4% 6.5% 5.6% 6.0% 7.9%
Other Noncurrent Assets 11.0% 8.1% 8.8% 8.8% 7.1% 5.5% 5.0% 2.3% 2.5% 1.2%
Total Assets 92.2% 83.7% 88.6% 89.1% 89.5% 91.2% 92.7% 89.2% 93.6% 86.4%
Liabilities
Accounts Payable 6.6% 5.6% 5.6% 6.4% 7.3% 5.7% 6.2% 6.7% 6.2% 5.8%
Accrued Liabilities 5.9% 4.8% 5.2% 5.2% 5.6% 6.4% 5.5% 5.3% 5.6% 5.3%
Current Portion of Long Term Debt 51.9% 4.7% 5.1% 2.7% 2.7% 1.6% 1.9% 1.7% 0.7% 0.8%
Other Current Liabilities 5.0% 5.0% 5.8% 4.9% 3.6% 2.9% 2.3% 2.5% 2.6% 1.9%
Total Current Liabilities 29.8% 30.2% 31.2% 29.3% 30.8% 27.2% 25.1% 25.0% 25.3% 23.4%
Long Term Debt 51.9% 47.3% 49.9% 48.7% 42.5% 41.6% 41.1% 33.6% 35.2% 34.9%
Deferred Tax Liabilities 3.8% 2.7% 2.9% 2.8% 1.7% 6.6% 6.7% 6.1% 6.3% 9.1%
Other Noncurrent Liabilities 7.4% 6.8% 8.6% 7.7% 9.8% 12.1% 11.1% 8.9% 11.1% 8.2%
Total Liabilities 92.8% 86.9% 92.5% 88.5% 84.9% 82.1% 78.7% 69.1% 73.5% 69.0%
Equity
Preferred Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Common Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Additional Paid In Capital 23.3% 23.2% 23.0% 21.7% 22.2% 26.1% 26.1% 26.0% 27.4% 29.1%
Retained Earnings 229.4% 216.2% 198.3% 171.6% 157.6% 165.2% 149.5% 134.3% 126.0% 122.2%
Treasury Stock 244.4% 233.7% 216.8% 186.9% 168.3% 171.3% 150.9% 129.9% 123.6% 119.9%
Accumulated Other Comprehensive Income -8.9% -8.9% -8.4% -5.8% -6.9% -10.9% -10.8% -10.3% -9.7% -14.2%
Total Stockholders Equity -0.6% -3.3% -4.0% 0.6% 4.6% 9.2% 14.0% 20.1% 20.1% 17.3%
Total Liabilitiesand Equity 92.2% 83.7% 88.6% 89.1% 89.5% 91.2% 92.7% 89.2% 93.6% 86.4%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +69.4% +69.4%
Operating margin +21.6% +22.3% +20.8% +22.3% +20.7% +19.5% +18.6% +17.5% +13.8% +15.3%
Net margin +21.6% +22.3% +20.8% +22.3% +20.7% +19.5% +18.6% +17.5% +13.8% +15.3%
FCF margin +21.1% +22.3% +22.7% +18.8% +21.6% +20.5% +16.8% +14.4% +14.3% +13.4%
Growth
Revenue CAGR (3y) +0.9% +1.4% +7.1% +9.2% +8.2% +4.2% +6.3% +7.0% +3.1% +1.8%
Returns
ROE -3677.4% -680.2% -526.1% +3519.1% +448.6% +213.2% +133.3% +86.9% +68.7% +88.4%
ROA +23.4% +26.6% +23.5% +25.0% +23.1% +21.4% +20.1% +19.6% +14.7% +17.7%
ROIC +17.6% +39.3% +34.3% +36.6% +35.5% +31.9% +30.7% +27.9% +17.9% +25.0%
Liquidity
Current ratio 1.14x 1.02x 1.04x 1.20x 1.11x 1.26x 1.47x 1.42x 1.46x 1.53x
Quick ratio 0.71x 0.64x 0.62x 0.70x 0.65x 0.82x 1.03x 0.97x 0.98x 1.04x
Leverage
D/E -158.08x -26.53x -23.38x 139.86x 18.41x 8.96x 5.63x 3.44x 3.66x 3.98x
Interest coverage 12.69x 11.57x 10.20x 15.75x 17.78x 15.61x 15.00x 14.85x 11.47x 13.71x
Efficiency
Asset turnover 1.08x 1.20x 1.13x 1.12x 1.12x 1.10x 1.08x 1.12x 1.07x 1.16x
Cash conversion cycle +109d +102d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds MTD to your watchlist.